Edwards Lifesciences Corp - Common Stock (EW)

Historical Holders from Q1 2014 to Q3 2025

Symbol
EW on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
590,231,680
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
490,576,046
Holdings value
$38,125,155,854
% of all portfolios
0.024%
Number of holders
1,235
Number of buys
532
Number of sells
-545
Average buys %
+0%
Average sells %
-0.02%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Edwards Lifesciences Corp - Common Stock (EW)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 11.72% $5,273,358,601 69,131,602 The Vanguard Group 31 Dec 2024
BlackRock, Inc. 7.5% $3,442,673,832 44,267,376 BlackRock, Inc. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 3.4% $1,547,456,998 19,826,483 Wellington Management Group LLP 30 Jun 2025

Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 490,576,046 $38,125,155,854 -$832,266,494 $77.77 1,235
2025 Q2 501,621,113 $39,209,886,931 +$342,427,261 $78.21 1,244
2025 Q1 498,551,233 $36,115,652,063 -$465,368,232 $72.48 1,190
2024 Q4 502,121,728 $37,169,453,852 +$1,434,005,846 $74.03 1,216
2024 Q3 476,335,956 $31,445,076,186 -$1,421,509,048 $65.99 1,173
2024 Q2 490,550,647 $45,304,945,713 +$713,718,504 $92.37 1,277
2024 Q1 485,320,749 $46,297,731,358 +$852,078,619 $95.56 1,262
2023 Q4 477,829,932 $36,429,234,865 -$1,182,014,878 $76.25 1,238
2023 Q3 493,332,184 $34,197,715,244 -$197,281,313 $69.28 1,208
2023 Q2 494,404,816 $46,545,398,964 -$181,795,991 $94.33 1,271
2023 Q1 496,146,114 $41,039,476,936 -$928,836,476 $82.73 1,232
2022 Q4 506,466,540 $37,809,986,212 -$183,554,159 $74.61 1,211
2022 Q3 508,531,260 $42,063,615,359 -$189,784,742 $82.63 1,228
2022 Q2 508,693,121 $48,384,102,646 +$312,787,497 $95.09 1,254
2022 Q1 507,560,223 $59,693,416,781 -$872,591,871 $117.72 1,299
2021 Q4 514,695,199 $66,609,194,753 -$186,675,822 $129.55 1,305
2021 Q3 513,353,562 $58,112,410,048 +$238,109,088 $113.21 1,216
2021 Q2 511,385,312 $52,958,914,663 +$538,462,811 $103.57 1,177
2021 Q1 507,991,100 $42,491,394,444 -$423,235,938 $83.64 1,126
2020 Q4 513,938,390 $46,860,598,892 +$9,977,557 $91.23 1,145
2020 Q3 514,029,273 $41,004,174,710 +$888,569,776 $79.82 1,071
2020 Q2 503,046,391 $34,793,459,237 +$22,859,029,603 $69.11 1,026
2020 Q1 168,719,752 $31,830,425,940 -$670,882,947 $188.62 994
2019 Q4 171,757,851 $40,049,515,897 +$49,626,361 $233.29 1,076
2019 Q3 171,570,027 $37,720,644,980 -$179,008,126 $219.91 952
2019 Q2 172,806,261 $31,924,084,222 +$289,583,036 $184.74 907
2019 Q1 175,225,854 $33,518,122,395 -$302,527,482 $191.33 915
2018 Q4 176,822,166 $27,082,266,094 +$78,816,316 $153.17 866
2018 Q3 175,353,101 $30,518,436,188 +$110,838,160 $174.1 846
2018 Q2 175,078,644 $25,484,757,626 +$115,064,600 $145.57 831
2018 Q1 174,088,441 $24,279,007,097 +$51,589,563 $139.52 806
2017 Q4 173,971,877 $19,610,101,151 -$379,710,789 $112.71 770
2017 Q3 176,631,416 $19,306,929,194 +$151,766,806 $109.31 738
2017 Q2 175,996,106 $20,807,081,462 +$123,201,458 $118.24 715
2017 Q1 176,531,453 $16,607,495,734 +$771,393,100 $94.07 681
2016 Q4 180,450,063 $16,904,815,239 -$153,832,535 $93.7 672
2016 Q3 179,768,954 $21,653,083,742 +$145,177,919 $120.56 689
2016 Q2 179,067,536 $17,857,436,721 -$88,134,950 $99.73 684
2016 Q1 180,474,875 $15,918,030,987 -$228,346,870 $88.21 640
2015 Q4 182,680,405 $14,427,556,075 +$7,504,740,825 $78.98 594
2015 Q3 87,881,992 $12,493,621,323 +$395,158,469 $142.17 560
2015 Q2 85,080,106 $12,117,685,386 -$825,149,875 $142.43 573
2015 Q1 90,872,311 $12,937,259,940 -$25,165,926 $142.46 567
2014 Q4 91,812,511 $11,696,363,623 -$61,719,579 $127.38 551
2014 Q3 92,070,273 $9,405,178,680 -$118,631,518 $102.15 484
2014 Q2 93,342,407 $8,012,433,007 -$352,899,046 $85.84 421
2014 Q1 97,604,601 $7,243,435,163 -$68,623,352 $74.17 402